Skip to main content
Value8 N.V. logo

Value8 N.V. — Investor Relations & Filings

Ticker · VALUE ISIN · NL0010661864 LEI · 724500IOX980PF17L830 AS Financial and insurance activities
Open in API
Filings indexed 503 across all filing types
Latest filing 2020-06-05 AGM Information
Country NL Netherlands
Listing AS VALUE

About Value8 N.V.

https://www.value8.com/

Value8 N.V. is an investment company that focuses on acquiring and managing holdings in small and medium-sized companies. The firm specializes in various investment strategies, including middle-market buyouts, add-on acquisitions, and providing growth capital. Its primary objective is to achieve long-term value creation for its portfolio companies. Value8 maintains a diverse portfolio with investments in sectors such as healthcare services and equipment, IT business and cloud integration, and platforms for independent professionals.

Recent filings

Filing Released Lang Actions
AVA Value8 keurt alle agendapunten met 99%+ meerderheid goed
AGM Information Classification · 99% confidence The document text explicitly discusses the results of the 'Algemene Vergadering van Aandeelhouders' (General Meeting of Shareholders), including the approval of agenda items, voting outcomes (Voor/Tegen/Onthouding), dividend announcements resulting from the meeting, and the reappointment of board members. This content directly relates to the proceedings and outcomes of an Annual General Meeting. Therefore, the appropriate classification is AGM Information (AGM-R). The document is a report of the results, not just an announcement of the meeting itself.
2020-06-05 Dutch
PAVO Zorghuizen (Value8) neemt twee vestigingen over
Regulatory Filings Classification · 100% confidence The document announces that PAVO Zorghuizen (a subsidiary of Value8) has completed the acquisition of two care facilities (Zorghuis Tegelen and Zorghuis Tienray) from BPG. This transaction was previously mentioned in an 'Aandeelhoudersbrief' (Shareholders Letter). The core subject is the completion of a business acquisition/takeover. This aligns best with the Merger & Acquisition Activity category (TAR), which covers merger proposals or takeover bids, even if this is the completion announcement rather than the initial proposal.
2020-06-04 Dutch
Kersten/Value8 in gesprek over doorstart HMC
Legal Proceedings Report Classification · 99% confidence The document is titled "PERSBERICHT" (Press Release) and announces ongoing discussions regarding the restart (doorstart) of HMC following its bankruptcy. It details the involvement of Kersten Hulpmiddelen and its shareholder Value8, provides financial context for Kersten, and mentions management changes. This type of announcement, concerning corporate activity, potential transactions (M&A/restructuring), and management/financial health updates, is typically released via a press release. Since it is not a formal regulatory filing like a 10-K, a specific financial report (IR, ER), or a formal shareholder communication (DEF 14A, AGM-R), and it relates to corporate structure/activity, it best fits the general 'Regulatory Filings' (RNS) category as a miscellaneous, non-standardized corporate announcement, or potentially 'M&A Activity' (TAR) due to the nature of the 'doorstart' (restructuring/takeover of assets). Given the focus is on the immediate corporate action and status update rather than a formal M&A bid, RNS serves as the most appropriate general regulatory announcement fallback for non-standard press releases.
2020-05-25 Dutch
AVA Value8 4 juni a.s.
AGM Information Classification · 98% confidence The document explicitly announces the date and time of the 'Algemene Vergadering van Aandeelhouders (AVA)' (Annual General Meeting) on June 4, 2020. It details proposals to be discussed and voted upon at this meeting, specifically regarding dividend proposals (€0.15 per common share, €1.75 per preferred share C) and two proposals for amending the articles of association (statuten), including changes to preferred share conditions and a potential tax-free capital distribution. Since the content focuses entirely on the agenda, proposals, and logistics for the upcoming AGM, the most appropriate classification is AGM Information (AGM-R). The document is an announcement/summary related to the AGM, not the final voting results (DVA) or a general regulatory filing (RNS).
2020-04-24 Norwegian
Aandeelhoudersbrief 10 april 2020
Report Publication Announcement Classification · 99% confidence The document is dated April 10, 2020, and begins by referencing the publication of annual figures for 2019 on April 1st. The text is structured as a letter to shareholders ('Geachte aandeelhouder', 'aandeelhoudersbrief') discussing recent investment activities (taking a stake in Ctac, investing in PAVO Zorghuizen, exiting BPG). This format, which follows the release of annual results and provides updates on strategy and transactions, strongly suggests it is a follow-up communication to investors, often accompanying or immediately succeeding the main annual report or earnings release. Since it is a detailed letter discussing specific transactions and strategy updates shortly after the annual results, it fits best as an Investor Presentation (IP) or a detailed Management Report (MDA). Given the narrative style and focus on explaining recent strategic moves following the annual results, 'Investor Presentation' (IP) is a strong fit, as these often take the form of detailed letters or presentations summarizing strategic actions post-results. However, because it explicitly discusses management's view on recent transactions and outlook following the annual results, 'Management Reports' (MDA) is also highly relevant. Since it is a letter detailing management's explanation of recent business activities and outlook following the annual results, MDA is slightly more precise than a general IP, although IP is also plausible. Given the context of discussing specific transactions and strategy updates immediately after the annual results, MDA (Management's detailed explanation of financial results, business trends, and outlook) is the most appropriate classification.
2020-04-10 Dutch
Intrinsieke waarde stijgt naar 7,15 euro per aandeel
Earnings Release Classification · 99% confidence The document is dated April 1, 2020, and presents key financial highlights for the calendar year 2019 ("Value8 publiceert cijfers over kalenderjaar 2019"). It details operational revenue, net profit, EPS, intrinsic value changes, and dividend proposals. Crucially, the final footnote states: "Deze interim-cijfers zijn gebaseerd op dezelfde grondslagen van waardering en resultaatbepaling , maar zijn niet door een accountant gecontroleerd of van een accountantsverklaring voorzien." This indicates it is a preliminary or summary release of periodic financial results, not the final audited Annual Report (10-K) or a comprehensive Interim Report (IR). It fits the definition of an Earnings Release (ER) as it announces key periodical financial results (annual results for 2019) immediately following the period end, even though it covers a full year. It is explicitly stated that the figures are unaudited interim figures, distinguishing it from a formal 10-K or AR. The document is substantial (nearly 10,000 characters) and contains detailed analysis, making it more than just a brief announcement, but its primary function is the initial release of the period's performance metrics. FY 2019
2020-04-01 Dutch

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.